Cayman Chemical 1 2 3TrIdocosahexaenoyl Glyc
A selective inhibitor of mutant EGFR that exhibits a 298-fold increase in potency compared with wild-type EGFR oral administration at 500 mg/kg regresses tumors with EGFR-active and T790M mutations in a xenograft model